The addition of pioglitazone in type 2 diabetics poorly controlled on insulin therapy: a meta-analysis
CRD SUMMARY: This review concluded that pioglitazone may improve glucose metabolism and lipid parameters in patients with type 2 diabetes inadequately controlled on insulin. The inappropriate synthesis employed means that the authors' conclusions should be treated with a considerable degree of caution since they are not based on randomised data.
